Literature DB >> 1369455

Expression of the human blood coagulation protein factor XIIIa in Saccharomyces cerevisiae: dependence of the expression levels from host-vector systems and medium conditions.

M Bröker1, O Bäuml, A Göttig, J Ochs, M Bodenbenner, E Amann.   

Abstract

The human blood coagulation protein Factor XIIIa (FXIIIa) was expressed in Saccharomyces cerevisiae employing Escherichia coli-yeast shuttle vectors based on a 2-mu plasmid. Several factors affecting high production yield of recombinant FXIIIa were analysed. The use of the regulatable GAL-CYC1 hybrid promoter resulted in higher FXIIIa expression when compared with the constitutive ADCI promoter. Screening for suitable yeast strains for expression of FXIIIa under the transcriptional control of the GAL-CYC1 hybrid promoter revealed a broad spectrum of productivity. No obvious correlation between the expression rate and the genetic markers of the strains could be identified. The medium composition markedly influenced the FXIIIa expression rates. The expression of FXIIIa was strictly regulated by the carbon source. Glucose as the only sugar and energy source repressed the synthesis of FXIIIa, whereas addition of galactose induced FXIIIa expression. Special feeding schemes resulted in a productivity of up to 100 mg FXIIIa/l in shake flasks.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1369455     DOI: 10.1007/bf00169346

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  29 in total

1.  Amino acid sequence of the a subunit of human factor XIII.

Authors:  A Ichinose; L E Hendrickson; K Fujikawa; E W Davie
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

2.  A simple method to recover intact high molecular weight RNA and DNA after electrophoretic separation in low gelling temperature agarose gels.

Authors:  L Wieslander
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

3.  Polymorphism of the A subunit of coagulation factor XIII: evidence for subtypes of the FXIIIA*1 and FXIIIA*2 alleles.

Authors:  K Suzuki; K Matsui; S Ito; K Fujita; H Matsumoto
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

4.  Characterization of cDNA coding for human factor XIIIa.

Authors:  U Grundmann; E Amann; G Zettlmeissl; H A Küpper
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virus.

Authors:  L D Schultz; J Tanner; K J Hofmann; E A Emini; J H Condra; R E Jones; E Kieff; R W Ellis
Journal:  Gene       Date:  1987       Impact factor: 3.688

6.  New expression vectors for the fission yeast Schizosaccharomyces pombe.

Authors:  M Bröker; O Bäuml
Journal:  FEBS Lett       Date:  1989-05-08       Impact factor: 4.124

7.  The relationship between mRNA stability and length in Saccharomyces cerevisiae.

Authors:  T C Santiago; I J Purvis; A J Bettany; A J Brown
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

8.  Effect of growth rate and expression level on plasmid stability in Saccharomyces cerevisiae.

Authors:  C Parker; D Dibiasio
Journal:  Biotechnol Bioeng       Date:  1987-02       Impact factor: 4.530

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Denaturation-renaturation of the fibrin-stabilizing factor XIII a-chain isolated from human placenta. Properties of the native and reconstituted protein.

Authors:  U Rinas; B Risse; R Jaenicke; K J Abel; G Zettlmeissl
Journal:  Biol Chem Hoppe Seyler       Date:  1990-01
View more
  6 in total

1.  Stable expression of recombinant human coagulation factor XIII in protein-free suspension culture of Chinese hamster ovary cells.

Authors:  B H Chun; W G Bang; Y K Park; S K Woo
Journal:  Cytotechnology       Date:  2001-11       Impact factor: 2.058

2.  Optimization of the expression system using galactose-inducible promoter for the production of anticoagulant hirudin in Saccharomyces cerevisiae.

Authors:  E S Choi; J H Sohn; S K Rhee
Journal:  Appl Microbiol Biotechnol       Date:  1994-12       Impact factor: 4.813

3.  New insight into Phaeodactylum tricornutum fatty acid metabolism. Cloning and functional characterization of plastidial and microsomal delta12-fatty acid desaturases.

Authors:  Frédéric Domergue; Patricia Spiekermann; Jens Lerchl; Christoph Beckmann; Oliver Kilian; Peter G Kroth; Wilhem Boland; Ulrich Zähringer; Ernst Heinz
Journal:  Plant Physiol       Date:  2003-04       Impact factor: 8.340

4.  Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Authors:  B U von Specht; B Knapp; G Muth; M Bröker; K D Hungerer; K D Diehl; K Massarrat; A Seemann; H Domdey
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

5.  Influence of pH, nitrogen and phosphorus sources on the production of hepatitis B virus pre-S2 antigen by Hansenula polymorpha.

Authors:  M R de Roubin; M D Cailas; S H Shen; D Groleau
Journal:  Appl Microbiol Biotechnol       Date:  1992-11       Impact factor: 4.813

Review 6.  Understanding marine mussel adhesion.

Authors:  Heather G Silverman; Francisco F Roberto
Journal:  Mar Biotechnol (NY)       Date:  2007-11-08       Impact factor: 3.619

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.